USPTO serial 97807966
PATHOS
Reviewed by CopyMark Law Group
Reg. 7509363Status 711
- Filing date
- Status date
- Registration date
- Sep 17, 2024
- Examiner
- SOLANO, CARLITA JAYE
- Law office
- PETITIONS OFFICE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PATHOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeremy D. Bisdorf
Jeremy D. Bisdorf TAFT STETTINIUS & HOLLISTER LLP27777 FRANKLIN RD., STE. 2500SOUTHFIELD, MI 48034United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Drug discovery services; pharmaceutical drug development services; development of oncology drugs; clinical research in the fields of oncology, precision medicine, and biomarker development; medical research in the fields of oncology, precision medicine, and biomarker development; platform as a service (PAAS) featuring computer software platforms utilizing artificial intelligence and machine learning-enabled computer software for use in managing clinical data platforms for oncology; structural and functional analysis of genomes; prediction being the analysis and reporting of medical and clinical outcomes to aid in drug development, medical and clinical research, and drug development; providing on-line non-downloadable software that enables users to collect, organize, and store genetic and genomic information of medical patients for diagnosis and treatment assistance; providing temporary use of online non-downloadable software being artificial intelligence and machine learning-enabled computer software for use in managing clinical and pre-clinical data platforms for oncology | SECTION 7(e) - CANCELLED | Jan 10, 2021 |
| 044 | Medical services in the fields of oncology, precision medicine, and biomarker development; providing medical information in the fields of oncology, precision medicine, and biomarker development | SECTION 7(e) - CANCELLED | Jan 10, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 15, 2025 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD | — |
| Aug 11, 2025 | HSCD | HIDDEN SENSITIVE CONTENT | — |
| Aug 8, 2025 | PCGR | PETITION TO DIRECTOR GRANTED | — |
| Jul 25, 2025 | NCS7 | NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED | — |
| Jul 25, 2025 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD | — |
| Jul 25, 2025 | C7.. | CANCELLED SECTION 7-TOTAL | — |
| Jul 24, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 7, 2025 | C7RF | REQUEST FOR SECT 7 TOTAL SURRENDER FILED | — |
| Jul 7, 2025 | ES7S | TEAS SECTION 7 SURRENDER RECEIVED | — |
| Jul 7, 2025 | ERTI | TEAS RESPONSE TO PETITION INQUIRY LETTER | — |
| Jun 5, 2025 | PILM | PETITION INQUIRY LETTER ISSUED | — |
| May 19, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 21, 2025 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Sep 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 13, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 13, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 3, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 1, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 23, 2024 | IUAF | USE AMENDMENT FILED | — |
| May 23, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 5, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 1, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 1, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 1, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 1, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2023 | NWAP | NEW APPLICATION ENTERED | — |